<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02832219</url>
  </required_header>
  <id_info>
    <org_study_id>16-AD</org_study_id>
    <nct_id>NCT02832219</nct_id>
  </id_info>
  <brief_title>Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity</brief_title>
  <official_title>Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Health, Exercise and Sport Sciences, Serbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Center for Health, Exercise and Sport Sciences, Serbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Molecular hydrogen (H2) effectively tackles obesity-related disorders in animal models yet no
      studies so far investigated the effectiveness of H2 for improving biomarkers of obesity in
      humans. In this double blind, placebo-controlled, crossover pilot trial, the investigators
      will evaluate the effects of H2 intervention on body composition, hormonal status, and
      mitochondrial function in middle age overweight women, with hydrogen administered orally for
      4 weeks.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">May 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body fat percentage change</measure>
    <time_frame>Baseline vs. four weeks</time_frame>
    <description>Baseline vs. four weeks</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Serum insulin change in IU/mL</measure>
    <time_frame>Baseline vs. four weeks</time_frame>
    <description>Baseline vs. four weeks</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Serum ghrelin change in IU/mL</measure>
    <time_frame>Baseline vs. four weeks</time_frame>
    <description>Baseline vs. four weeks</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Molecular hydrogen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Molecular hydrogen, tablet, 2 g/day, 4 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Cellulose, tablet, 2 g/day, 4 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Molecular hydrogen</intervention_name>
    <arm_group_label>Molecular hydrogen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &gt; 55 years

          -  body mass index &gt; 25 kg/m2

        Exclusion Criteria:

          -  no history of H2 supplementation within the 4 weeks before study commenced

          -  no major chronic diseases, as evaluated by pre-participation health screening and
             clinical chemistry
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Center for Health, Exercise and Sport Sciences</name>
      <address>
        <city>Belgrade</city>
        <zip>11000</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <reference>
    <citation>Ostojic SM. Molecular hydrogen: An inert gas turns clinically effective. Ann Med. 2015 Jun;47(4):301-4. doi: 10.3109/07853890.2015.1034765. Epub 2015 May 4. Review.</citation>
    <PMID>25936365</PMID>
  </reference>
  <reference>
    <citation>Huang CS, Kawamura T, Toyoda Y, Nakao A. Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res. 2010 Sep;44(9):971-82. doi: 10.3109/10715762.2010.500328. Review.</citation>
    <PMID>20815764</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2016</study_first_submitted>
  <study_first_submitted_qc>July 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 14, 2016</study_first_posted>
  <last_update_submitted>July 11, 2016</last_update_submitted>
  <last_update_submitted_qc>July 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 14, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Center for Health, Exercise and Sport Sciences, Serbia</investigator_affiliation>
    <investigator_full_name>Assoc. Prof. Sergej M. Ostojic, MD, PhD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Overweight</keyword>
  <keyword>Molecular hydrogen</keyword>
  <keyword>Insulin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

